Dark Horse for Huge Appreciation.
UPDATE ON TRIVENI GLASS LTD:
FINANCIAL RESULTS:
Q3/FY16. Q3/FY15
Sales 15.11. 10.73
Net Profit 2.29. -1.50
Equity 12.62
TGL has reported sharply improved results for quarter ended Dec2015 wherein its Net Profit is 2.28 crores as against LOSS of 1.50 crores in corresponding quarter of previous year. Q3 Eps is Rs 1.82. EPS for 9 months is 3.54. Profitability in ensuing quarters should be much better due to installation of energy saving equipment imported from China.
MAJOR TRIGGER(UPDATE ON LAND SALE): Company has already RECEIVED advance payment of Rs 23.12 crores (refer Auditor review at Bse website) against sale of land at Allahabad. However, company has not yet made official announcement of same to Bse as approval of land sale is awaited from IDBI. But LAND SALE DEAL DONE. As per our information, total value of Land sale is Rs 72 crores which works out to Rs 57 PER
SHARE. Further, TGL may be able to get another Rs 30-35 crores from sale of its Plant/Equipment (TGL was manufacturing float glass in Allahabad plant). OTS with Canara Bank DONE. LETTER OF OTS FROM IDBI
EXPECTED ANYDAY.
TGL may have to shell out roughly Rs 50 crores against discharge of ENTIRE liabilities (OTS payment to IDBI, other small liabilities and statutory payments). Thus after sale of Plant/Machnery, TGL should have CASH of nearly Rs 50 crores. THIS CASH WORKS OUT TO Rs 38 PER SHARE. Market cap is just Rs 20 crores although cash in hand is likely to be 50 crores.
Further TGL will report EPS of Rs 9 for FY17 and Rs 12 for FY18
Stock price can cross Rs 100 mark in 2017. Investors may , at present juncture, feel such steep price target as impractical. However, even more steep rise in our past recommendations has taken place. Before starting of this blog, MANGALAM DRUGS was recommended by us @ Rs 7 (yes Rs Seven only) in 2014. In just 18 months, M Drugs touched Rs 400+
UPDATE ON TRIVENI GLASS LTD:
FINANCIAL RESULTS:
Q3/FY16. Q3/FY15
Sales 15.11. 10.73
Net Profit 2.29. -1.50
Equity 12.62
TGL has reported sharply improved results for quarter ended Dec2015 wherein its Net Profit is 2.28 crores as against LOSS of 1.50 crores in corresponding quarter of previous year. Q3 Eps is Rs 1.82. EPS for 9 months is 3.54. Profitability in ensuing quarters should be much better due to installation of energy saving equipment imported from China.
MAJOR TRIGGER(UPDATE ON LAND SALE): Company has already RECEIVED advance payment of Rs 23.12 crores (refer Auditor review at Bse website) against sale of land at Allahabad. However, company has not yet made official announcement of same to Bse as approval of land sale is awaited from IDBI. But LAND SALE DEAL DONE. As per our information, total value of Land sale is Rs 72 crores which works out to Rs 57 PER
SHARE. Further, TGL may be able to get another Rs 30-35 crores from sale of its Plant/Equipment (TGL was manufacturing float glass in Allahabad plant). OTS with Canara Bank DONE. LETTER OF OTS FROM IDBI
EXPECTED ANYDAY.
TGL may have to shell out roughly Rs 50 crores against discharge of ENTIRE liabilities (OTS payment to IDBI, other small liabilities and statutory payments). Thus after sale of Plant/Machnery, TGL should have CASH of nearly Rs 50 crores. THIS CASH WORKS OUT TO Rs 38 PER SHARE. Market cap is just Rs 20 crores although cash in hand is likely to be 50 crores.
Further TGL will report EPS of Rs 9 for FY17 and Rs 12 for FY18
Stock price can cross Rs 100 mark in 2017. Investors may , at present juncture, feel such steep price target as impractical. However, even more steep rise in our past recommendations has taken place. Before starting of this blog, MANGALAM DRUGS was recommended by us @ Rs 7 (yes Rs Seven only) in 2014. In just 18 months, M Drugs touched Rs 400+
Sir can you update us about noble explochem
ReplyDeleteAny update on Visaka Ind
ReplyDelete